Medicare Enrolled
Dr. Joseph Briskie, DO
Cardiovascular Disease · Wilkes Barre, PA
Practice pattern: Electrophysiology & Cardiac
— Practice combining electrophysiology and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Briskie from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Briskie?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Briskie
Dr. Joseph Briskie is a cardiovascular disease specialist in Wilkes Barre, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Briskie performed 6,095 Medicare services across 4,320 unique beneficiaries.
Between the years covered by Open Payments, Dr. Briskie received a total of $10,662 from 33 pharmaceutical and/or device companies across 690 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Briskie is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in PA
$10,662 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,095
Medicare services
Top 4% in PA for cardiovascular disease
4,320
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~305 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
973 | $137 | $650 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
661 | $9 | $45 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
653 | $82 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
360 | $55 | $150 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
311 | $47 | $75 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
267 | $15 | $50 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
231 | $4 | $20 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
216 | $130 | $500 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
212 | $45 | $350 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
211 | $17 | $50 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
211 | $24 | $78 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
198 | $21 | $75 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
182 | $41 | $125 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
169 | $82 | $215 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
165 | $315 | $800 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
125 | $23 | $100 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
125 | $132 | $250 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
120 | $90 | $148 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
113 | $60 | $125 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
76 | $132 | $500 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
70 | $25 | $140 |
| Implantable defibrillator system check A check of the implanted defibrillator device to ensure it is functioning correctly. This evaluation covers single, dual, or multiple lead systems. |
54 | $55 | $125 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
53 | $109 | $200 |
| Pacemaker insertion with heart chamber electrodes A surgical procedure to implant a pacemaker device and place electrodes into the upper and lower chambers of the heart to regulate heart rhythm. |
49 | $394 | $1,500 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
44 | $14 | $50 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
31 | $21 | $100 |
| Pacemaker and lower heart chamber electrode insertion A surgical procedure to implant a pacemaker device and place an electrode in the lower chamber of the heart to help regulate the heartbeat. |
29 | $360 | $1,500 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
29 | $76 | $350 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
29 | $173 | $600 |
| Removal and replacement of dual lead permanent pacemaker This procedure involves removing an existing permanent pacemaker with two leads and replacing it with a new device. It is performed to update or repair the heart rhythm management system. |
21 | $260 | $1,000 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
19 | $32 | $125 |
| Programming of single lead implantable defibrillator system Adjustment and testing of the settings for a single-lead implantable cardioverter-defibrillator (ICD) to ensure proper function. |
17 | $23 | $125 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
17 | $73 | $300 |
| Nuclear medicine heart pumping function test A nuclear medicine study that labels red blood cells to measure the volume of blood ejected from the heart with each beat over multiple cycles. |
14 | $147 | $450 |
| Technetium Tc-99m red blood cell scan A diagnostic nuclear medicine imaging study using Technetium Tc-99m labeled red blood cells to visualize blood flow or detect bleeding. |
14 | $214 | $300 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
13 | $80 | $300 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $40 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
33.4% high complexity
20.0% medium
46.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,662
Total received (2018-2024)
Avg $1,523/year across 7 years
Top 20% in PA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
690
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,910 (93.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$752 (7.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,361
2023
$1,254
2022
$1,273
2021
$2,517
2020
$1,255
2019
$1,492
2018
$1,510
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$256
Novartis Pharmaceuticals Corporation
$255
Janssen Pharmaceuticals, Inc
$150
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$148
Boston Scientific Corporation
$112
Daiichi Sankyo Inc.
$92
SCPHARMACEUTICALS INC.
$62
Impulse Dynamics (USA) Inc.
$50
Novo Nordisk Inc
$42
PFIZER INC.
$33
E.R. Squibb & Sons, L.L.C.
$33
HEARTFLOW, INC.
$27
Actelion Pharmaceuticals US, Inc.
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Merck Sharp & Dohme LLC
$17
Kiniksa Pharmaceuticals International, plc
$15
AltaThera Pharmaceuticals LLC
$15
Amgen Inc.
$14
Top 3 companies account for 48.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,173
Janssen Pharmaceuticals, Inc
$1,394
Amgen Inc.
$1,199
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,006
AstraZeneca Pharmaceuticals LP
$936
Abbott Laboratories
$893
PFIZER INC.
$760
Boehringer Ingelheim Pharmaceuticals, Inc.
$331
E.R. Squibb & Sons, L.L.C.
$246
SANOFI-AVENTIS U.S. LLC
$214
Merck Sharp & Dohme LLC
$198
Boston Scientific Corporation
$151
Lantheus Medical Imaging, Inc.
$151
Regeneron Healthcare Solutions, Inc.
$140
Gilead Sciences, Inc.
$114
Esperion Therapeutics, Inc.
$97
Daiichi Sankyo Inc.
$92
Novo Nordisk Inc
$83
SCPHARMACEUTICALS INC.
$62
Kiniksa Pharmaceuticals, Ltd.
$52
Impulse Dynamics (USA) Inc.
$50
Amarin Pharma Inc.
$42
Merck Sharp & Dohme Corporation
$41
Kowa Pharmaceuticals America, Inc.
$39
Relypsa, Inc.
$30
Davol Inc.
$30
AltaThera Pharmaceuticals LLC
$28
HEARTFLOW, INC.
$27
Actelion Pharmaceuticals US, Inc.
$21
Vifor Pharma, Inc.
$20
Kiniksa Pharmaceuticals International, plc
$15
Allergan Inc.
$13
Braemar Manufacturing, LLC
$13
Top 3 companies account for 44.7% of all-time payments
Associated products mentioned in payments ›
AVEIR · Accent Pacemaker · Arcalyst · BRILINTA · BYSTOLIC · CAMZYOS · CHANTIX · CONFIRM RX · Cardiac Monitoring Suite · CardioMEMS HF System · Corlanor · DEFINITY · Definity · ELIQUIS · ENTRESTO · FARXIGA · FFRct · FUROSCIX · GENERAL STENTS · Gallant CRT-D · INJECTAFER · JARDIANCE · JOT DX · LEQVIO · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MULTAQ · NEXLETOL · OPSUMIT · Optimizer · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR 20 · Prolia · Repatha · Rybelsus · SYNERGY · Sotalol Hydrochloride · VERQUVO · Vascepa · Veltassa · WATCHMAN · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
36
Per 100K population
11.0
County median income
$62,321
Nearest hospital
GEISINGER BEHAVIORAL HEALTH CENTER NORTHEAST
9.7 mi
9.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Briskie is an electrophysiology & cardiac specialist, with above-average Medicare volume (top 4% in PA), with low-engagement industry engagement in the top 20% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Briskie experienced with echocardiogram, transthoracic?
Based on Medicare claims data, Dr. Briskie performed 973 echocardiogram, transthoracic services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Briskie receive payments from pharmaceutical companies?
Yes. Dr. Briskie received a total of $10,662 from 33 companies across 690 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Briskie's costs compare to other cardiologists in Wilkes Barre?
Dr. Briskie's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Briskie) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Wilkes Barre
Browse cardiologists in Wilkes Barre ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in PA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in PA
Which PA cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology